Target type: biologicalprocess
A cardiac conduction process that modulates the extent of heart contraction, changing the force with which blood is propelled. [GOC:BHF, GOC:mtg_cardiac_conduct_nov11]
The regulation of the force of heart contraction, known as **contractility**, is intricately linked to the cardiac conduction system. This system, a network of specialized cardiac muscle cells, orchestrates the rhythmic beating of the heart by generating and propagating electrical impulses. The conduction system ensures coordinated contraction of the heart chambers, propelling blood efficiently throughout the body. Here's a detailed explanation of how the conduction system regulates heart contractility:
**1. Action Potential Generation and Conduction:**
- The heart's electrical activity begins in the **sinoatrial (SA) node**, the heart's natural pacemaker, located in the right atrium.
- The SA node spontaneously generates electrical impulses, triggering a rhythmic sequence of depolarization and repolarization in cardiac muscle cells. This electrical activity is represented as an **action potential**.
- The action potential spreads rapidly through the atrial muscle, causing atrial contraction.
- It then reaches the **atrioventricular (AV) node**, located at the junction between the atria and ventricles.
- The AV node acts as a gate, slowing down the conduction of the electrical impulse, allowing the ventricles to fill with blood before they contract.
- The impulse then travels through the **bundle of His**, a specialized conductive pathway, and branches into the **Purkinje fibers** which extend throughout the ventricular myocardium.
- The Purkinje fibers rapidly distribute the electrical impulse to all ventricular muscle cells, leading to synchronized ventricular contraction.
**2. Calcium-Mediated Contraction:**
- The arrival of the action potential at the ventricular muscle cells triggers the release of calcium ions (Ca2+) from the sarcoplasmic reticulum, the intracellular calcium store.
- The influx of Ca2+ into the cytoplasm initiates the process of muscle contraction by interacting with proteins called **troponin and tropomyosin**.
- These proteins regulate the interaction between the contractile proteins **actin and myosin**, which slide past each other to generate force.
**3. Modulation of Contractility:**
- The force of ventricular contraction, or contractility, can be modulated by several factors that influence calcium levels and the sensitivity of the contractile proteins to calcium:
- **Sympathetic Nervous System Activation:** The sympathetic nervous system, part of the autonomic nervous system, releases norepinephrine, a neurotransmitter that increases the rate and force of heart contractions. This is achieved by:
- Increasing the rate of action potential generation in the SA node.
- Accelerating conduction through the AV node.
- Enhancing calcium release from the sarcoplasmic reticulum.
- **Parasympathetic Nervous System Activation:** The parasympathetic nervous system, another part of the autonomic nervous system, releases acetylcholine, a neurotransmitter that decreases heart rate and force of contraction. This effect is primarily mediated by slowing down conduction through the AV node.
- **Hormonal Influences:** Hormones such as epinephrine (adrenaline) and thyroid hormones can also increase contractility by mechanisms similar to those of the sympathetic nervous system.
- **Drugs:** Medications like digitalis can increase contractility by enhancing calcium levels and sensitivity to calcium.
**4. Importance of Conduction Regulation:**
- The precise regulation of cardiac conduction is critical for maintaining normal heart function.
- Abnormalities in the conduction system can lead to irregular heart rhythms (arrhythmias), which can impair the heart's ability to pump blood effectively, potentially causing serious health problems.
**5. Summary:**
- The cardiac conduction system plays a crucial role in regulating the force of heart contraction.
- By generating and propagating electrical impulses, the conduction system ensures coordinated contraction of the heart chambers.
- The force of contraction can be modulated by factors like the autonomic nervous system, hormones, and drugs, affecting calcium levels and contractile protein sensitivity to calcium.
- The intricate interplay between electrical activity and calcium signaling within the heart muscle is fundamental to regulating heart contractility and maintaining cardiovascular health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sodium/hydrogen exchanger 1 | A sodium/hydrogen exchanger 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19634] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ethylisopropylamiloride | ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group. ethylisopropylamiloride: structure in first source | aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound | anti-arrhythmia drug; neuroprotective agent; sodium channel blocker |
benzotriazole | benzotriazole : The simplest member of the class of benzotriazoles that consists of a benzene nucleus fused to a 1H-1,2,3-triazole ring. benzotriazole: inhibitor of atmospheric metal corrosion; also component of motion picture film & Neva brake fluid | benzotriazoles | environmental contaminant; xenobiotic |
amiloride | amiloride : A member of the class of pyrazines resulting from the formal monoacylation of guanidine with the carboxy group of 3,5-diamino-6-chloropyrazine-2-carboxylic acid. Amiloride: A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705) | aromatic amine; guanidines; organochlorine compound; pyrazines | diuretic; sodium channel blocker |
amiloride hydrochloride | amiloride hydrochloride dihydrate : A hydrate that is the dihydrate of amiloride hydrochloride. | hydrate | diuretic; sodium channel blocker |
cariporide | cariporide: a selective sodium-hydrogen exchange subtype 1 inhibitor; structure in first source | ||
eniporide | eniporide: inhibits NHE-1 isoform; structure in first source | ||
zoniporide | zoniporide: inhibits sodium-hydrogen exchanger isoform-1 (NHE-1) | ||
sabiporide | sabiporide: a NHE-1 inhibitor and a cardioprotective agent; structure in first source | ||
(5-(2-methoxy-5-chloro-5-phenyl)furan-2-ylcarbonyl)guanidine | (5-(2-methoxy-5-chloro-5-phenyl)furan-2-ylcarbonyl)guanidine: KR-32570 possesses potent cardioprotective effects in perfused rat hearts, and its effects may be mediated by inhibition of NHE-1, preservation of high-energy phosphates, and inhibition of lipid peroxidation |